$16.63
arrow_drop_up2.52%Key Stats | |
---|---|
Open | $16.12 |
Prev. Close | $16.21 |
EPS | -3.64 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 15.51 | 17.36 |
52 Week Range | 11.21 | 25.34 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -3.64 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
Syndax (SNDX) is on the Move, Here's Why the Trend Could be Sustainable
Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates
Analyst Ratings for Syndax Pharmaceuticals